Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 58

1.

Gut microbial diversity in HIV infection post combined antiretroviral therapy: a key target for prevention of cardiovascular disease.

El-Far M, Tremblay CL.

Curr Opin HIV AIDS. 2018 Jan;13(1):38-44. doi: 10.1097/COH.0000000000000426.

2.

Combined use of nuclear phosphoprotein c-Myc and cellular phosphoprotein p53 for hepatocellular carcinoma detection in high-risk chronic hepatitis C patients.

Attallah AM, El-Far M, Abdelrazek MA, Omran MM, Attallah AA, Elkhouly AA, Elkenawy HM, Farid K.

Br J Biomed Sci. 2017 Oct;74(4):170-175. doi: 10.1080/09674845.2017.1334739. Epub 2017 Jul 13.

PMID:
28705056
3.

Circulating levels of collagen III and MMP-1 in patients with chronic hepatitis C co-infected with hepatitis B virus.

Attallah AM, El-Far M, Ghaly MF, Omran MM, Albannan MS, Attallah AA, Shoghey TM, Atrees MM, Elbendary MS, Farid K.

Br J Biomed Sci. 2017 Apr;74(2):95-100. doi: 10.1080/09674845.2017.1278888. Epub 2017 Feb 28.

PMID:
28367737
4.

GPC-HCC model: a combination of glybican-3 with other routine parameters improves the diagnostic efficacy in hepatocellular carcinoma.

Attallah AM, El-Far M, Omran MM, Abdelrazek MA, Attallah AA, Saeed AM, Farid K.

Tumour Biol. 2016 Sep;37(9):12571-12577. Epub 2016 Jul 5.

PMID:
27380057
5.

HCV RNA Activates APCs via TLR7/TLR8 While Virus Selectively Stimulates Macrophages Without Inducing Antiviral Responses.

Zhang Y, El-Far M, Dupuy FP, Abdel-Hakeem MS, He Z, Procopio FA, Shi Y, Haddad EK, Ancuta P, Sekaly RP, Said EA.

Sci Rep. 2016 Jul 7;6:29447. doi: 10.1038/srep29447.

6.

Kynurenine Reduces Memory CD4 T-Cell Survival by Interfering with Interleukin-2 Signaling Early during HIV-1 Infection.

Dagenais-Lussier X, Aounallah M, Mehraj V, El-Far M, Tremblay C, Sekaly RP, Routy JP, van Grevenynghe J.

J Virol. 2016 Aug 12;90(17):7967-79. doi: 10.1128/JVI.00994-16. Print 2016 Sep 1.

7.

Interferon-gamma is associated with hepatic dysfunction in fibrosis, cirrhosis, and hepatocellular carcinoma.

Attallah AM, El-Far M, Zahran F, Shiha GE, Farid K, Omran MM, Abdelrazek MA, Attallah AA, El-Beh AA, El-Hosiny RM, El-Waseef AM.

J Immunoassay Immunochem. 2016;37(6):597-610. doi: 10.1080/15321819.2016.1179646.

PMID:
27093468
8.

Proinflammatory isoforms of IL-32 as novel and robust biomarkers for control failure in HIV-infected slow progressors.

El-Far M, Kouassi P, Sylla M, Zhang Y, Fouda A, Fabre T, Goulet JP, van Grevenynghe J, Lee T, Singer J, Harris M, Baril JG, Trottier B, Ancuta P, Routy JP, Bernard N, Tremblay CL; Investigators of the Canadian HIV+ Slow Progressor Cohort.

Sci Rep. 2016 Mar 15;6:22902. doi: 10.1038/srep22902.

9.

Current topics in HIV pathogenesis, part 2: Inflammation drives a Warburg-like effect on the metabolism of HIV-infected subjects.

Aounallah M, Dagenais-Lussier X, El-Far M, Mehraj V, Jenabian MA, Routy JP, van Grevenynghe J.

Cytokine Growth Factor Rev. 2016 Apr;28:1-10. doi: 10.1016/j.cytogfr.2016.01.001. Epub 2016 Jan 27. Review.

PMID:
26851985
10.

Levels of Schistosoma mansoni Circulating Antigen in Chronic Hepatitis C Patients with Different Stages of Liver Fibrosis.

Attallah AM, El-Far M, Omran MM, Farid K, Attallah AA, Abd-Elaziz D, El-Bendary MS, El-Dosoky I, Ismail H.

J Immunoassay Immunochem. 2016;37(3):316-30. doi: 10.1080/15321819.2015.1135163.

PMID:
26745203
11.

Identification of novel HIV-1 dependency factors in primary CCR4(+)CCR6(+)Th17 cells via a genome-wide transcriptional approach.

Cleret-Buhot A, Zhang Y, Planas D, Goulet JP, Monteiro P, Gosselin A, Wacleche VS, Tremblay CL, Jenabian MA, Routy JP, El-Far M, Chomont N, Haddad EK, Sekaly RP, Ancuta P.

Retrovirology. 2015 Dec 10;12:102. doi: 10.1186/s12977-015-0226-9.

12.

A simple diagnostic index comprising epithelial membrane antigen and fibronectin for hepatocellular carcinoma.

Attallah AM, El-Far M, Abdel Malak CA, Farid K, Omran MM, Yahya RS, Saad EA, Albannan MS, Attallah AA, El Basuni MA, Ali IS, Abed SB, El Naggar MA.

Ann Hepatol. 2015 Nov-Dec;14(6):869-80. doi: 10.5604/16652681.1171774.

PMID:
26436359
13.

Current topics in HIV-1 pathogenesis: The emergence of deregulated immuno-metabolism in HIV-infected subjects.

Dagenais-Lussier X, Mouna A, Routy JP, Tremblay C, Sekaly RP, El-Far M, Grevenynghe Jv.

Cytokine Growth Factor Rev. 2015 Dec;26(6):603-13. doi: 10.1016/j.cytogfr.2015.09.001. Epub 2015 Sep 8. Review.

PMID:
26409789
14.

Segmentation of 3D Meshes Using p-Spectral Clustering.

Chahhou M, Moumoun L, El Far M, Gadi T.

IEEE Trans Pattern Anal Mach Intell. 2014 Aug;36(8):1687-93. doi: 10.1109/TPAMI.2013.2297314.

PMID:
26353348
15.

Combined use of epithelial membrane antigen and nuclear matrix protein 52 as sensitive biomarkers for detection of bladder cancer.

Attallah AM, El-Far M, Abdallah SO, El-Waseef AM, Omran MM, Abdelrazek MA, Attallah AA, Saadh MJ, Radwan M, El-waffaey KA, Abol-Enei H.

Int J Biol Markers. 2015 Nov 11;30(4):e407-13. doi: 10.5301/jbm.5000164.

PMID:
26349665
16.

HCC-DETECT: a combination of nuclear, cytoplasmic, and oncofetal proteins as biomarkers for hepatocellular carcinoma.

Attallah AM, El-Far M, Malak CA, Omran MM, Shiha GE, Farid K, Barakat LA, Albannan MS, Attallah AA, Abdelrazek MA, Elbendary MS, Sabry R, Hamoda GA, Elshemy MM, Ragab AA, Foda BM, Abdallah SO.

Tumour Biol. 2015 Sep;36(10):7667-74. doi: 10.1007/s13277-015-3501-4. Epub 2015 May 1.

PMID:
25929809
17.

Perinatal transmission of hepatitis C antigens: envelope 1, envelope 2 and non-structural 4.

Attallah AM, Abdallah SO, El-Far M, Omran MM, Tabll AA, Ghaly MF, Ezzat SM, Elhamshary MO, El-Gohary ZM, Mohamedin AH, El-Morsi AA, Askora AA, Abdelrazek MA, El-Kafrawy HM, Keneber MH, Khalil MR, Aggag MM, Elbendary MS, El-Deeb MM, Abuzaid MS, Mansour AT, Attallah AA.

Infect Dis (Lond). 2015 Aug;47(8):568-74. doi: 10.3109/23744235.2015.1042035. Epub 2015 Apr 29.

PMID:
25922972
18.

Fibro-check: a combination of direct and indirect markers for liver fibrosis staging in chronic hepatitis C patients.

Attallah AM, El-Far M, Abdel Malak CA, Omran MM, Farid K, Hussien MA, Albannan MS, Attallah AA, Elbendary MS, Elbesh DA, Elmenier NA, Abdallah MO.

Ann Hepatol. 2015 Mar-Apr;14(2):225-33.

19.

Nef promotes evasion of human immunodeficiency virus type 1-infected cells from the CTLA-4-mediated inhibition of T-cell activation.

El-Far M, Ancuta P, Routy JP, Zhang Y, Bakeman W, Bordi R, DaFonseca S, Said EA, Gosselin A, Tep TS, Eichbaum Q, van Grevenynghe J, Schwartz O, Freeman GJ, Haddad EK, Chomont N, Sékaly RP.

J Gen Virol. 2015 Jun;96(Pt 6):1463-77. doi: 10.1099/vir.0.000065. Epub 2015 Jan 27.

20.

Immunosuppressive Tryptophan Catabolism and Gut Mucosal Dysfunction Following Early HIV Infection.

Jenabian MA, El-Far M, Vyboh K, Kema I, Costiniuk CT, Thomas R, Baril JG, LeBlanc R, Kanagaratham C, Radzioch D, Allam O, Ahmad A, Lebouché B, Tremblay C, Ancuta P, Routy JP; Montreal Primary infection and Slow Progressor Study Groups.

J Infect Dis. 2015 Aug 1;212(3):355-66. doi: 10.1093/infdis/jiv037. Epub 2015 Jan 23.

PMID:
25616404

Supplemental Content

Loading ...
Support Center